Oxford Study Reassures on Statin Safety
Analysis based on 28 articles · First reported Feb 06, 2026 · Last updated Feb 17, 2026
The study's findings are expected to increase patient confidence in statins, potentially leading to higher prescription rates and improved public health outcomes. This positive sentiment could benefit pharmaceutical companies producing statins and healthcare providers.
A major study led by the University of Oxford's Cholesterol Treatment Trialists' Collaboration, involving 23 randomized trials and over 150,000 participants, found that most commonly reported statin side effects are not directly caused by the medication. Researchers, including Christina Reith and Rory Collins, concluded that statins are safe and effective, with only minor increases in abnormal liver blood tests and a slight rise in blood sugar levels for those at high risk of diabetes. Bryan Williams of the British Heart Foundation emphasized the importance of these findings in countering misinformation and preventing cardiovascular deaths. The study calls for a rapid revision of statin warning labels to better inform patients and doctors.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard